Mark E Nance

CIK 1755882 · General Counsel · last filed 2026-02-27

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.69M

Companies

3

Total Filings

27

Lifetime Open-Market Net

-$779.4K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NVST General Counsel 68,577 $24.60 $1.69M -$779.4K 23 2026-02-27
Envista Holdings Corp (NVSTw) Delisted Senior Vice President, GC, Sec 9,156 $0 1 2019-12-20
Insys Therapeutics, Inc. (INSY) Delisted Chief Legal Officer & Gen Cnsl 25,000 $0 3 2019-04-23

Recent Filings · Page 3 of 3

27 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-02-17 NVST Grant (A) $0 EDGAR
2020-07-17 NVST Tax (F) −540 -$11.8K EDGAR
2020-02-26 NVST Grant (A) +11,325 $0 EDGAR
2019-12-20 Envista Holdings Corp (NVSTw) Delisted Grant (A) +9,156 $0 EDGAR
2019-04-23 Insys Therapeutics, Inc. (INSY) Delisted Grant (A) +10,000 $0 EDGAR
2019-04-19 Insys Therapeutics, Inc. (INSY) Delisted Grant (A) +10,000 $0 EDGAR
2018-10-12 Insys Therapeutics, Inc. (INSY) Delisted Grant (A) +15,000 $0 EDGAR
Showing 2127 of 27
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.